The European Commission’s flagship research and innovation event returns this autumn, bringing together policymakers, researchers, business leaders and the public to set the course for Europe’s future in science and technology.
Dr Richard Hodes, Director of the National Institute on Aging within the U.S. National Institutes of Health, explores the importance of working together to treat and prevent Alzheimer’s disease and related dementias.
Simon Gillespie, Chief Executive of the British Heart Foundation ponders if escalating diabetes rates could reverse success in reducing heart disease deaths
In this interview, public health specialist Dr Wilfred Alexander Chalamira Nkhoma from the World Health Organization (WHO) Office for the Africa Region speaks to us about the priorities for tackling infectious diseases in Africa, with a particular focus on Tuberculosis (TB) and viral hepatitis.
Ethical Healthcare Consulting asks if current suppliers can survive the coming revolution as the company looks to the future of the Electronic Patient Record (EPR).
Regina Fluhrer from the LMU & DZNE in Munich explains an aspect of health research that concerns how proteases embedded in cellular membranes hydrolyse other proteins and the challenges they must overcome.
Electron microscopy is the primary method for analyzing nanostructures. Senior researcher Thomas Willum Hansen discusses the new challenges in this field.
The effects of climate change threaten food security worldwide. What needs to be done to improve the resilience of vital dryland cereals to more extreme weather?
Professor Nam H. Cho, President of the International Diabetes Federation (IDF) explains why governments across the world could and should do more to help people with diabetes and their families.
Following its inception last year, the Blockchain Live event returned to the Olympia in London yesterday (Wednesday 26th October), to host another stellar line up of Blockchain founders and innovators.
Asthma UK’s recent report explores the barriers to life-changing treatment for people with uncontrolled asthma, as Joe Farrington-Douglas, Head of Policy and External Affairs at Asthma UK explains.
